Abstract:Objective: This study was conducted to evaluate the difference in acid inhibition function among lansoprazole (LPZ), pantoprazole (PPZ), and their respective stereoisomers following single and multiple intravenous doses in healthy Chinese subjects. Materials and methods: The dosage groups were set as follows: 30 mg single and multiple intravenous administrations of LPZ or R-LPZ. 40 mg single and multiple intravenous administrations of PPZ or S-PPZ. Subjects received an intravenous infusion of LPZ, R-LPZ, PPZ, or S-PPZ injection in sterile saline solution (100 mL/h, 60 minutes), respectively. The intragastric pH was sampled every second for 24 hours at baseline and for 24 hours after drug administration. The baseline-adjusted pharmacodynamic (PD) parameters include Delta Mean (pH), Delta Median (pH), Delta T-pH >= 3 (%), Delta T-pH >= 4 (%), Delta T-pH >= 6 (%), and Delta AUEC(tau 1-tau 2)(pH-t) The PD parameters were evaluated in different time intervals (0 - 24 hours. 0 - 4 hours and 14 - 24 hours).Results: After a single dose. the Delta T-PH >= 4 (%) of R-LPZ, LPZ, S-PPZ and PPZ was 56.6 +/- 19.6. 53.1 +/- 23.3, 35.6 +/- 24.9 and 26.8 +/- 30.2, respectively. The Delta T-PH >= 6 (%) was 50.7 +/- 26.1, 41.4 +/- 26.2, 25.4 +/- 24.9 and 22.1 +/- 27.6, respectively. The Delta AUEC(tau 1-tau 2)(pH- )was 45,564 +/- 16,107, 41,798 +/- 16,153, 31,914 +/- 17,304 and 20,744 +/- 21,500, respectively. Statistically significant differences were found with R-LPZ vs. S-PPZ, R-LPZ vs. PPZ, LPZ vs. S-PPZ and LPZ vs. PPZ. The average Delta T-PH >= 4 of R-LPZ, LPZ, S-PPZ, and PPZ was (47.2 +/- 26.1) minutes, (49.6 +/- 19.3) minutes, (56.1 +/- 23.7) minutes, and (72.1 +/- 27.3) minutes, respectively. Statistically significant differences were found with R-LPZ vs. PPZ (p = 0.009) and LPZ vs. PPZ (p = 0.019). After multiple doses, the Delta T-PH >= 4 (%) of R-LPZ, LPZ, S-PPZ, and PPZ was 71.7 +/- 20.2, 63.5 +/- 19.4, 59.5 +/- 17.8 and 64.0 +/- 22.4, respectively. The Delta T-PH >= 6 (%) was 64.0 +/- 22.2, 52.0 +/- 19.2. 49.6 +/- 20.4 and 50.9 +/- 23.8, respectively. The Delta AUEC(tau 1-tau 2)(pH)(-) was 326,149 +/- 94,839, 288,565 +/- 93,279, 296,189 +/- 83,412 and 300,960 +/- 108,057, respectively. No statistically significant differences were found in baseline-adjusted PD parameters during all time periods after multiple doses.Conclusion: After a single dose, the mean gastric pH inhibition value of R-LPZ was the highest, followed by LPZ. then S-PPZ and PPZ. R-LPZ and LPZ provided significantly better pH control compared with PPZ and S-PPZ in healthy subjects. The onset time of R-LPZ was the fastest and R-LPZ can provide better acid inhibition during sleeping time. After multiple doses, the mean values in all PD parameters of R-LPZ were the highest, the values of LPZ, S-PPZ, and PPZ were similar. However, no significant difference was found in acid inhibition among these four drugs after multiple doses.

Safety, tolerability, pharmacokinetics and pharmacodynamics of dexlansoprazole injection in healthy Chinese subjects

Safety, Pharmacokinetics/Pharmacodynamics, and Absolute Bioavailability of Dexmedetomidine Hydrochloride Nasal Spray in Healthy Subjects: A Randomized, Parallel, Escalating Dose Study

Determination of lansoprazole in healthy human plasma by LC-MS/MS:application to pharmacokinetics study

Pharmacokinetic study of dexamethasone palmitate injection in Chinese healthy volunteers

Pharmacokinetics of Lansoprazole and Its Main Metabolites after Single and Multiple Intravenous Doses in Healthy Chinese Subjects.

Safety, Tolerability, and Pharmacokinetics of Anaprazole, a Novel Proton Pump Inhibitor, in Healthy Chinese Subjects.

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Safety, Tolerability and Pharmacokinetics of Single Dose Polyethylene Glycolated Exenatide Injection (PB-119) in Healthy Volunteers

Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Oral Formulations of Calcium Dobesilate Capsules in Healthy Chinese Volunteers Under Fasting and Fed Conditions

Tolerance of soxifloxacin hydrochloride tablet after ascending single dose in Chinese healthy subjects

Pharmacokinetics of Dexibuprofen in Rats after Oral Administration of Dexibuprofen and Dexibuprofen Arginate

Pharmacokinetics and Tolerability of Intravenous Ibuprofen Injection in Healthy Chinese Volunteers: a Randomized, Open-Label, Single- and Multiple-Dose Study

Parmacokinetics of pazufloxacin mesilate sodium chloride injection in Chinese healthy volunteers

Pharmacokinetics of Dapoxetine Hydrochloride in Chinese Healthy Male Volunteers

Comparison of the Gastric Acid Inhibition Function among Lansoprazole, Pantoprazole, and Their Respective Stereoisomers in Healthy Chinese Subjects

Pharmacokinetics and Safety of Fosaprepitant Dimeglumine in Healthy Chinese Volunteers: Bioequivalence Study

Pharmacokinetics study of pazufloxacin mesylate in single dose in Chinese healthy volunteers

A First-in-human Safety, Tolerability and Pharmacokinetics study of Benapenem in Healthy Chinese Volunteers.

Safety, Tolerability, and Pharmacokinetics of Voriconazole for Injection in Two Preparations in Chinese Healthy Adult Volunteers

Effect of Esomeprazole and Rabeprazole on Intragastric Ph in Healthy Chinese: an Open, Randomized Crossover Trial

Pharmacokinetics and safety of levosimendan injection in Chinese healthy volunteers